$MCY

MERCURY GENERAL CORP

4
4
0

No SEC Form 4 filings for $MCY in the last 30 days.

Med

Oil shock impact? What to expect from this reporting season

Market commentary ahead of New Zealand and Australian reporting season cites expectations for RBNZ tightening and higher retail rates. Analysts highlight focus on bellwethers including Freightways, Air NZ, Sky TV, and power generators Contact, Mercury, Meridian, and Genesis. Forsyth Barr forecasts strong profit growth but clipped 2027 estimates. Contact results may be boosted by Manawa Energy ($2.3b). Air NZ faces higher jet fuel costs, with expected loss before tax of $340m to $390m.

3 Stocks to Watch After Crushing Q2 Earnings Expectations: CAT, MCY & ZBRA

Zacks highlights Q2 results for Caterpillar (CAT), Mercury General (MCY) and Zebra Technologies (ZBRA). CAT reported adjusted EPS of $8.17 vs $6.25 expected, revenue $20.54B vs $19.31B, and raised full-year sales outlook. MCY posted adjusted EPS $3.52 vs $1.80, revenue $1.67B vs $1.58B. ZBRA reported adjusted EPS $6.35 vs $4.35, revenue $1.55B vs $1.49B, and lifted full-year guidance.

Mercury General (MCY) Stock Looks Cheap As Margins Strengthen And Risks Linger

Simply Wall St reports Mercury General (MCY) shares rose 2.8% to $109.61. It cites improving profitability, with trailing net profit margin at 13.7% vs 5.1% a year earlier and Q2 2026 revenue of $1,539.8m and net income of $190.4m. It also notes the combined ratio worsened to 89.3% from 87.0% amid catastrophe-related reserve issues.

MCY sentiment & insider activity

Over the past 7 days, alphai's AI scored 8 news stories mentioning MCY (MERCURY GENERAL CORP). Coverage has skewed bullish: 4 bullish, 4 neutral, and 0 bearish.

Recent MCY coverage spans earnings, sector analysis and financial news.

What's driving MCY

  • Investors will likely re-rate generator earnings power versus prior-year volatility, but guidance may remain conservative.

    nzherald.co.nz · Aug 6, 2026

  • Turnaround signals from underwriting, pricing, and higher investment income support continued earnings estimate upgrades.

    zacks.com · Aug 6, 2026

  • The piece frames MCY as potentially undervalued on low P/E while warning underwriting margin pressure from a higher combined ratio and catastrophe reserve development.

    simplywall.st · Aug 5, 2026

  • The article attributes MCY’s same-day upside to a clear earnings beat and better underwriting profitability (combined ratio), which can reset near-term sentiment.

    financialcontent.com · Aug 5, 2026

  • The article discloses a fresh earnings-style datapoint (revenue and GAAP EPS beats) plus an immediate post-report price reaction, supporting near-term bullish repricing.

    financialcontent.com · Aug 4, 2026

alphai scores every news story that mentions MCY with an AI model for sentiment and relevance, and aggregates insider trades from MERCURY GENERAL CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MCY

Score

Oil shock impact? What to expect from this reporting season

Market commentary ahead of New Zealand and Australian reporting season cites expectations for RBNZ tightening and higher retail rates. Analysts highlight focus on bellwethers including Freightways, Air NZ, Sky TV, and power generators Contact, Mercury, Meridian, and Genesis. Forsyth Barr forecasts strong profit growth but clipped 2027 estimates. Contact results may be boosted by Manawa Energy ($2.3b). Air NZ faces higher jet fuel costs, with expected loss before tax of $340m to $390m.

$CATMed

3 Stocks to Watch After Crushing Q2 Earnings Expectations: CAT, MCY & ZBRA

Zacks highlights Q2 results for Caterpillar (CAT), Mercury General (MCY) and Zebra Technologies (ZBRA). CAT reported adjusted EPS of $8.17 vs $6.25 expected, revenue $20.54B vs $19.31B, and raised full-year sales outlook. MCY posted adjusted EPS $3.52 vs $1.80, revenue $1.67B vs $1.58B. ZBRA reported adjusted EPS $6.35 vs $4.35, revenue $1.55B vs $1.49B, and lifted full-year guidance.

Why Mercury General (MCY) Stock Is Up Today

Mercury General (MCY) shares rose about 1.6% after the insurer reported strong Q2 2026 results. GAAP profit was $4.76 per share, up over 58% year over year and above the $1.80 consensus. Revenue increased 14% to $1.68 billion. The combined ratio improved to 89.9% versus a 97.2% estimate. Shares traded around $109.18.

$MCYMedAI 8/10

MERCURY GENERAL CORP (MCY): Results of Operations and Financial Condition

MERCURY GENERAL CORP (MCY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d61051dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 4484 Wilshire Boulevard Los Angeles, California 90010 (323) 937-1060 Fax (323) 857-7125 Press Release FOR MORE INFORMATION, CONTACT: Theodore Stalick, SVP/CFO (323) 937-1060 www.mercuryinsurance.com For Release: August 4, 20

$MCYMed

Mercury General (MCY) Reports Earnings Tomorrow: What To Expect

Mercury General (NYSE:MCY) will report earnings Tuesday after market close. The insurer reported $1.54B revenue last quarter, up 10.5% year over year, and beat analysts’ revenue and EPS estimates. For the upcoming quarter, analysts expect 3.3% revenue growth. The article cites an average price target of $120 versus $107.12.

Mercury General Set to Report Q2 Earnings: What to Expect?

Mercury General Corporation (MCY) is expected to register a decrease in its top and bottom lines when it reports second-quarter 2026 results on Aug. 4, after the closing bell. The Zacks Consensus Estimate for MCY’s second-quarter revenues is pegged at $1.6 billion, indicating 7.8% decline from the year-ago reported figure. The consensus estimate for earnings is pegged at $1.80 per share. The Zacks Consensus Estimate for MCY’s second-quarter earnings suggests a 32.6% year-over-year decrease.

$WASTMed

Quick Takes of the Week to July 24

WasteCo said Roger Gower stepped down as director and chair, with Sean Joyce replacing him. WasteCo reported FY26 revenue up 24% to $70.2m but a net loss of $12.35m. Tower appointed Len Elikhis as permanent CFO. Stats NZ put June-quarter inflation at 4.1%. AFT Pharma received tentative FDA approval for Scomara. SkyCity outlined a non-binding Grand Hotel sale deal.

Related tickers